POTENTIAL ROLE FOR KETONE BODY METABOLISM IN AN SGLT2 INHIBITOR-MEDIATED ANTI-ALBUMINURIC EFFECT IN TYPE 2 DIABETIC DB/DB MICE

被引：0
|
作者：
Kume, Shinji [1 ]
Tomita, Issei [1 ]
Yamahara, Kosuke [1 ]
Yasuda-Yamahara, Mako [1 ]
Takeda, Naoko [1 ]
Osawa, Norihisa [1 ]
Chin-Kanasaki, Masami [1 ]
Kaneko, Tatsuroh [2 ]
Pieper, Michael [2 ]
Araki, Shin-Ichi [1 ]
Maegawa, Hiroshi [1 ]
机构：
[1] Shiga Univ Med Sci, Otsu, Shiga, Japan
[2] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP430
引用
收藏
页码：504 / 504
页数：1
相关论文
共 50 条
  • [1] Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic β-cells in obese type 2 diabetic db/db mice
    Okauchi, Seizo
    Shimoda, Masashi
    Obata, Atsushi
    Kimura, Tomohiko
    Hirukawa, Hidenori
    Kohara, Kenji
    Mune, Tomoatsu
    Kaku, Kohei
    Kaneto, Hideaki
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 470 (03) : 772 - 782
  • [2] Protective Effects of SGLT2 Inhibitor Luseogliflozin on Pancreatic Beta Cells in Obese Type 2 Diabetic db/db Mice
    Okauchi, Seizou
    Simoda, Masashi
    Obata, Atsushi
    Kimura, Tomohiko
    Hirukawa, Hidenori
    Kohara, Kenji
    Kaneto, Hideaki
    Kaku, Kohei
    [J]. DIABETES, 2015, 64 : A586 - A586
  • [3] Sodium Glucose Transporter Type 2 (SGLT2) Inhibitor, Empagliflozin, Improves Diastolic Function in Female Diabetic db/db Mice
    Demarco, Vincent G.
    Aroor, Annayya R.
    Nistala, Ravi
    Garro, Mona
    Mayoux, Eric W.
    Whaley-Connell, Adam
    Sowers, James R.
    [J]. DIABETES, 2015, 64 : A552 - A552
  • [4] ROLE OF KETONE BODY METABOLISM IN SGLT2 INHIBITOR-MEDIATED RENOPROTECTION IN HIGH FAT DIET-FED APOE-KNOCKOUT MICE
    Tomita, Issei
    Kume, Shinji
    Yamahara, Kosuke
    Yasuda-Yamahara, Mako
    Takeda, Naoko
    Osawa, Norihisa
    Chin-Kanasaki, Masami
    Kaneko, Tatsuroh
    Pieper, Michael
    Araki, Shin-Ichi
    Maegawa, Hiroshi
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 25 - 25
  • [5] Nephropathy in diabetic db/db mice is accelerated by high protein diet and improved by the SGLT2 inhibitor dapagliflozin
    Norgaard, Sisse Andersen
    Briand, Francois
    Sand, Fredrik Wolfhagen
    Galsgaard, Elisabeth Douglas
    Sondergaard, Henrik
    Sorensen, Dorte Bratbo
    Sulpice, Thierry
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 860
  • [6] Luseogliflozin (TS-071), a novel SGLT2 inhibitor, protects against diabetic nephropathy in diabetic db/db mice
    Takiyama, Y.
    Agatsuma, K.
    Yasuda-Kobayashi, M.
    Honjo, J.
    Fujita, Y.
    Yanagimachi, T.
    Kitsunai, H.
    Makino, Y.
    Haneda, M.
    [J]. DIABETOLOGIA, 2013, 56 : S66 - S66
  • [7] ROLE OF KETONE BODY-INDUCED MTORC1 INHIBITION IN SGLT2 INHIBITOR-MEDIATED RENOPROTECTION
    Tomita, Issei
    Kume, Shinji
    Sugahara, Sho
    Yamahara, Kosuke
    Yamahara, Mako
    Takeda, Naoko
    Osawa, Norihisa
    Kanasaki, Masami
    Kaneko, Tatsuro
    Michael, Mark
    Yanagita, Motoko
    Araki, Shin-Ichi
    Maegawa, Hiroshi
    [J]. NEPHROLOGY, 2020, 25 : 18 - 18
  • [8] The SGLT2 Inhibitor, Empagliflozin, Attenuates Some Markers of Renal Fibrosis without Improving Albuminuria in Diabetic Db/Db Mice
    Gallo, Linda A.
    Ward, Micheal S.
    Fotheringham, Amelia K.
    Zhuang, Aowen
    Koepsell, Hermann
    Vallon', Volker
    Pollock, Carol
    Panchapakesan, Usha
    Forbes, Josephine M.
    [J]. FASEB JOURNAL, 2016, 30
  • [9] IN DB/DB MICE, SGLT2 INHIBITION DOES NOT IMPROVE DIABETIC NEPHROPATHY DESPITE GLYCAEMIC IMPROVEMENTS
    Gallo, L. A.
    Ward, M. S.
    Fotheringham, A. K.
    Pollock, C.
    Panchapakesan, U.
    Forbes, J. M.
    [J]. NEPHROLOGY, 2015, 20 : 24 - 24
  • [10] SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in db/db Mice, a Model of Type 2 Diabetes
    Korbut, Anton I.
    Taskaeva, Iuliia S.
    Bgatova, Nataliya P.
    Muraleva, Natalia A.
    Orlov, Nikolai B.
    Dashkin, Maksim V.
    Khotskina, Anna S.
    Zavyalov, Evgenii L.
    Konenkov, Vladimir I.
    Klein, Thomas
    Klimontov, Vadim V.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (08)
12345